Shanghai Henlius Biotech announced that the FDA has granted Orphan Drug Designation for HLX22, an anti-HER2 monoclonal ...
Henlius (2696.HK) announced its 2024 annual results. During the reporting period, Henlius' total revenue reached approximately ...
LUND, SE / ACCESS Newswire / March 20, 2025 /Alligator Bioscience (Nasdaq Stockholm:ATORX) today announces that the U.S. Food ...
The FDA granted orphan drug designation to HLX22 for gastric cancer, advancing global phase 3 trials to improve first-line ...
Vici Energy, an integrated energy company, announced today the opening of its new Renovo Energy (Renovo) trading desk in ...
SkySpecs, a global leader in renewable energy asset health management, autonomous drone inspections, and tech-enabled software solutions, has raised $20 million in strategic growth capital led by ...
Shanghai Henlius Biotech, Inc. (2696.HK) announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for HLX22, the company's innovative anti-HER2 monoclonal ...
StoneFly, Inc. (iscsi.com) a leader in storage, HCI, backup and disaster recovery, cloud, and AI storage solutions, has announced a significant update to its DR365V appliance, integrating a Secure ...
Marwan G. Fakih, MD, discusses the next steps for the clinical development of the balstilimab plus botensilimab in microsatellite stable metastatic colorectal cancer without liver metastases. Marwan G ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback